Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
dopamine agonist |
| gptkbp:CASNumber |
62717-42-4
|
| gptkbp:drugClass |
D1 receptor agonist
|
| gptkbp:hasInChIKey |
QXWJZNOZBJNQBG-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C16H17NO2
|
| gptkbp:hasSMILES |
C1CNCC2=CC(=C(C=C21)O)O
|
| https://www.w3.org/2000/01/rdf-schema#label |
SKF-38393
|
| gptkbp:IUPACName |
(±)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
|
| gptkbp:molecularWeight |
255.31 g/mol
|
| gptkbp:PubChem_CID |
5196
CHEMBL1167 |
| gptkbp:studiedBy |
gptkb:Parkinson's_disease
neuroscience |
| gptkbp:synonym |
(±)-SKF-38393
SKF 38393 hydrochloride 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol |
| gptkbp:UNII |
8X7Q0I84HV
|
| gptkbp:bfsParent |
gptkb:dopamine_receptor_D1
gptkb:dopamine_receptor_D5 |
| gptkbp:bfsLayer |
7
|